EVis Bioscience

Schlieren, Switzerland

EVis Bioscience offers gene delivery solutions using extracellular vesicles, lipid nanoparticles, and hybrid systems.

$873K raised

Feb 2026

Pre-Seed

Genetics Nanotechnology

Top Investors

Capital Cell Innosuisse

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about EVis Bioscience

How much funding has EVis Bioscience raised?

EVis Bioscience has raised $873K in total funding. The most recent round was Pre-Seed. The last funding was announced in February 2026.

Who are EVis Bioscience's investors?

EVis Bioscience's investors include Capital Cell, Innosuisse.

Where is EVis Bioscience headquartered?

EVis Bioscience is headquartered in Schlieren, Switzerland.

What does EVis Bioscience do?

EVis Bioscience offers gene delivery solutions using extracellular vesicles, lipid nanoparticles, and hybrid systems.

What stage is EVis Bioscience at?

EVis Bioscience is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 23, 2026.

MLA

"EVis Bioscience — Funding & Investors." VCBacked, February 23, 2026, https://www.vcbacked.co/company/evis-bioscience. Accessed July 2, 2026.

APA

VCBacked. (2026). EVis Bioscience — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/evis-bioscience

Wikipedia (cite web)

{{cite web |title=EVis Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/evis-bioscience |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 23, 2026.

Similar Companies in Genetics